McCormack, Sheena <br/><br/>
PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial.  [electronic resource] 

 -  Lancet (London, England)  Oct 2010 
 - 1329-37 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1474-547X 
<br/><br/><label>Standard No.: </label>10.1016/S0140-6736(10)61086-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Africa South of the Sahara--epidemiology<br/>Antiviral Agents--administration & dosage<br/>Condoms--statistics & numerical data<br/>Double-Blind Method<br/>Female<br/>HIV Infections--epidemiology<br/>HIV-1<br/>Humans<br/>Middle Aged<br/>Naphthalenesulfonates--administration & dosage<br/>Polymers--administration & dosage<br/>Sexual Behavior<br/>Sexually Transmitted Diseases--prevention & control<br/>Vaginal Creams, Foams, and Jellies--adverse effects<br/>Young Adult